Insider Transactions in Q3 2021 at Bridge Bio Pharma, Inc. (BBIO)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 16
2021
|
Neil Kumar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,730
-0.08%
|
$182,770
$49.48 P/Share
|
|
Aug 16
2021
|
Neil Kumar Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,523
+0.16%
|
-
|
|
Aug 16
2021
|
Brian C Stephenson Secretary, Treasurer & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,028
-0.34%
|
$50,372
$49.48 P/Share
|
|
Aug 16
2021
|
Brian C Stephenson Secretary, Treasurer & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,487
+0.81%
|
-
|
|
Aug 04
2021
|
Richard H Scheller Director |
SELL
Open market or private sale
|
Direct |
13,777
-23.1%
|
$730,181
$53.23 P/Share
|
|
Aug 04
2021
|
Richard H Scheller Director |
BUY
Exercise of conversion of derivative security
|
Direct |
13,777
+18.77%
|
$234,209
$17.0 P/Share
|